Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McDermott

Showing results (361-370 of 567) with videos related to

Pageof 57
Sort By:
Journal of Medical Genetics|June 4, 1998
Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian feverM F McDermott, E M McDermott, K A Quane, et al.
Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.
Frontiers in Oncology|February 27, 2023
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanomaAnn W Silk, Brendan Curti, Jennifer Bryan, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Plos One|September 26, 2013
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Orso Maria Lucherini, Laura Obici, Manuela Ferracin, et al.
Life Science Alliance|December 29, 2019
TRAP1 chaperone protein mutations and autoinflammationAriane Si Standing, Ying Hong, Coro Paisan-Ruiz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinomaRana R McKay, Michael Serzan, Wanling Xie, et al.
Pageof 57

Showing results (361-370 of 567) with videos related to

Sort By:
Pageof 57
Journal of Medical Genetics|June 4, 1998
Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian feverM F McDermott, E M McDermott, K A Quane, et al.
Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.
Frontiers in Oncology|February 27, 2023
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanomaAnn W Silk, Brendan Curti, Jennifer Bryan, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Plos One|September 26, 2013
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Orso Maria Lucherini, Laura Obici, Manuela Ferracin, et al.
Life Science Alliance|December 29, 2019
TRAP1 chaperone protein mutations and autoinflammationAriane Si Standing, Ying Hong, Coro Paisan-Ruiz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinomaRana R McKay, Michael Serzan, Wanling Xie, et al.
Pageof 57